Stanford M. Shoor, MD - Rheumatology
Dr. Stanford Shoor reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Shoor, an internist specializing in rheumatology, has been on the Clinical Faculty of Stanford University since 1986 and currently holds an appointment as an Adjunct Clinical Professor of Medicine and Rheumatology.
Dr. Shoor has served as principal investigator or co-investigator for a number of research projects sponsored by Kaiser Health Plan and the Stanford Arthritis Center. He serves on the medical review boards for the Journal of General Internal Medicine, Permanente Journal, ACP Journal, and the Evidence Based Medicine section of the British Medical Journal (BMJ).
- American Board of Internal Medicine—1982
- American Board of Internal Medicine, Subspecialty: Rheumatology—1984
Healthwise Knowledgebase Topics Reviewed
- Juvenile Rheumatoid Arthritis
- Medical Tests: Antinuclear Antibodies, Erythrocyte Sedimentation Rate, Rheumatoid Factor
- Raynaud's Syndrome
- Rheumatoid Arthritis
- Sjögren's Syndrome
- Systemic Lupus Erythematosus
- M.D.: Stanford University School of Medicine, 1979
- Internship, University of Washington, 1978–1980
- Residency, University of Washington, 1980–1982
- Robert Wood Johnson Clinical Scholar, Stanford University School of Medicine, 1982–1984
- Fellowship in Immunology, Stanford University School of Medicine, 1982–1984
- Adjunct Clinical Professor of Medicine and Rheumatology, Stanford University, 1986–present
- Staff Director, Mid-Peninsula Health Service, 1973–1975
- Internist, Rheumatology, Kaiser Foundation Hospital, Santa Clara, California, 1984–present
- Chief of Professional Education, Kaiser Foundation Hospital, Santa Clara, 1988–present
- O'Leary A, Shoor SM, Lorig K, Holman HR (1988). A cognitive-behavioral treatment for rheumatoid arthritis. Health Psychology 7(6): 527–544.
- Lorig K, Chastain RL, Ung E, Shoor S, Holman HR (1989). Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis and Rheumatology 32(1): 37–44.
- Graham, DJ, Campen D, Hui R, Spence M, Cheetham C, Shoor S, Ray W (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective nonsteroidal anti-inflammatory drugs: Nested case control study. Lancet, 365(9468): 475–481.
- Herrinton L, Liu L, Shoor S, Mines D (2008). Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Annals of the Rheumatic Diseases, 67(4): 574–575.